This image has an empty alt attribute; its file name is Immagine-WhatsApp-2023-12-04-ore-10.44.45_6c76537b-1024x695.jpg

The NeuroSolve consortium held its Project Kick-off Meeting on the 4th December 2023 in Lusaka (Zambia). NeuroSolve is a four-year project funded by EDCTP3, lead by an African-European research consortium involves the University of Dar es Salaam (UDSM – Tanzania), Sokoine University of Agriculture (SUA – Tanzania), University of Zambia (UNZA – Zambia), Revolution Worldwide Srl – Impresa Sociale (R-EvoWW – Italy) and Universiteit Ghent (UGent – Belgium).

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

HANTAAN-VAX-EU-Proposal submitted under the Horizon Europe call for a multiplatform vaccine against Hantaan virus

Hantaan virus (HTNV) is one of the main causes of haemorrhagic fever with renal syndrome (HFRS), a severe disease affecting endemic regions across Asia, with growing concern over its geographical

R-Evolution Worldwide as part of a multidisciplinary team of African and European researchers developed the VectorEnd project.

The increasing urbanization in Africa, paralleled by inadequate environmental sanitation, significantly contributes to the proliferation of Aedes mosquitoes, which transmit many arboviruses, including dengue virus (DENV) and Chikungunya virus (CHIKV). In 

OPTIMAL-RSV AFRICA PROPOSAL SUBMITTED TO EDCTP3 TO IMPROVING NEWBORN PROTECTION AGAINTS RESPIRATORY INFECTION IN AFRICA

Respiratory infections remain one of the main causes of illness and death among newborns in sub-Saharan Africa. Respiratory Syncytial Virus (RSV) is a major contributor to severe disease in the